TY - JOUR
T1 - Primary Sjögren's syndrome in men
AU - Anaya, Juan Manuel
AU - Liu, George Tye
AU - D'Souza, Errol
AU - Ogawa, Noriyoshi
AU - Luan, Xianghong
AU - Talal, Norman
N1 - Funding Information:
From the Division of Clinical Immunology, partment of Internal Medicine, the Department Dermatology, the Division of Clinical Immunology, and the Division of Medical Genetics, The Johns Hopkins Medical Institutions, Baltimore, Maryland. This work was supported in part by National Institutes of Health grants (HL 30748, OPD-CRC 5M OlRR00722, AM 07324, AM 28412, AM 25650) Arthritis Foundation Clinical Research Center Grant and Arthritis Investigator Award, and a Kroc Foundation grant. This work was presented in part at the American Rheumatism Association Meetings, San Antonio, Texas, June 1983. Requests for reprints should be addressed to Dr. Elaine L. Alexander, The Johns Hopkins Medical Institutions, Division of Clinical Immunology, c/o Good Samaritan Hospital, 5601 Loch Raven Boulevard, Baltimore, Maryland 21239. Manuscript accepted February 13, 1985.
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1995
Y1 - 1995
N2 - Objective-To describe the clinical expression ofprimary Sjogren's syndrome (SS) in men, focusing on extraglandular mm festations (EGM) and serological markers of disease. Methods-In a cross sectional and comparative study, adult men with primary SS were identified from a cohort study on SS, and 26 age matched adult women with primary SS were selected as a control group. AUR patients met the European classification criteria for SS. They were compared for demographic, clinical and laboratory findings. Results-Thirteen men with primary SS were identified. Mean age at onset was 39 (SEM 4) years and mean duration of disease was 7-8 (1) years. Sicca complex or parotitis was the presenting feature in eight patients (61-5%), and an EGM in five (38-5%). During the course of the disease, EGM were present in 12 patients (92%), polyarthralgias and lymphopenia being the most frequent (38.5% each). Rheumatoid factor was positive in 73% of patients, antinuclear antibodies in 85%S anti-(SS-A) in 62%, and anti-(SS-B) in 46%. No statistical differences in the frequency of EGM or in the presence of autoantibodies were observed between men and women. However, men patients were more likely to have EGM. Conclusion-Primary SS in men is an uncommon condition with clinical and serological characteristics similar to those observed in women. Sex hormones may be incriminated in the pathogenesis of SS. However, it remains poorly understood whether sex hormones play a major role in the severity of disease and have any importance with regard to treatment.
AB - Objective-To describe the clinical expression ofprimary Sjogren's syndrome (SS) in men, focusing on extraglandular mm festations (EGM) and serological markers of disease. Methods-In a cross sectional and comparative study, adult men with primary SS were identified from a cohort study on SS, and 26 age matched adult women with primary SS were selected as a control group. AUR patients met the European classification criteria for SS. They were compared for demographic, clinical and laboratory findings. Results-Thirteen men with primary SS were identified. Mean age at onset was 39 (SEM 4) years and mean duration of disease was 7-8 (1) years. Sicca complex or parotitis was the presenting feature in eight patients (61-5%), and an EGM in five (38-5%). During the course of the disease, EGM were present in 12 patients (92%), polyarthralgias and lymphopenia being the most frequent (38.5% each). Rheumatoid factor was positive in 73% of patients, antinuclear antibodies in 85%S anti-(SS-A) in 62%, and anti-(SS-B) in 46%. No statistical differences in the frequency of EGM or in the presence of autoantibodies were observed between men and women. However, men patients were more likely to have EGM. Conclusion-Primary SS in men is an uncommon condition with clinical and serological characteristics similar to those observed in women. Sex hormones may be incriminated in the pathogenesis of SS. However, it remains poorly understood whether sex hormones play a major role in the severity of disease and have any importance with regard to treatment.
UR - http://www.scopus.com/inward/record.url?scp=0028991766&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028991766&partnerID=8YFLogxK
U2 - 10.1136/ard.54.9.748
DO - 10.1136/ard.54.9.748
M3 - Research Article
C2 - 7495348
AN - SCOPUS:0028991766
SN - 0003-4967
VL - 54
SP - 748
EP - 751
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 9
ER -